CIK 0000820318 · Large accelerated filer
COHERENT CORP.
Sign in to watch- Ticker
- COHR
- Exchange
- NYSE
- Industry
- Optical Instruments & Lenses
- FY end
- Jun 30
- Incorporated
- PA
- Entity type
- operating
- EIN
- 251214948
- Phone
- 724-352-4455
- Business address
- 375 SAXONBURG BLVD, SAXONBURG, PA, 16056
- Former names
- II-VI INC
- Open-market buys, last 90 days
- $1,220,285
- in 2 filings
- Open-market sales, last 90 days
- $8,184,635
- in 7 filings, $5.8M under 10b5-1 plans
Net −$6,964,350. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-15 | Koeppen Christopher Chief Innovation Officer | Sale 10b5-1 | −100 | $98.03 | $10K | 63,092 |
| 2024-11-14 | Koeppen Christopher Chief Innovation Officer | Option exercise 10b5-1 | +1,740 | $35.25 | $61K | 67,888 |
| 2024-11-14 | Koeppen Christopher Chief Innovation Officer | Option exercise 10b5-1 | +1,380 | $49.90 | $69K | 69,268 |
| 2024-11-14 | Koeppen Christopher Chief Innovation Officer | Sale 10b5-1 | −4,176 | $103.18 | $431K | 65,092 |
| 2024-11-14 | Koeppen Christopher Chief Innovation Officer | Option exercise · Option (Right to Buy) 10b5-1 | −1,740 | 0 | ||
| 2024-11-14 | Koeppen Christopher Chief Innovation Officer | Option exercise · Option (Right to Buy) 10b5-1 | −1,380 | 0 | ||
| 2024-11-13 | Patrick Elizabeth Director | Sale | −2,000 | $104.00 | $208K | 6,373 |
| 2024-11-13 | Patrick Elizabeth Director | Sale | −3,542 | $105.00 | $372K | 2,831 |
| 2024-10-21 | Beard Robert P Chief Legal Officer | Grant or award | +39,088 | 39,088 | ||
| 2024-10-11 | Luther Sherri R Chief Financial Officer | Grant or award | +79,056 | $70.55 | $5.6M | 79,056 |
| 2024-10-01 | Koeppen Christopher Chief Innovation Officer | Sale 10b5-1 | −1,899 | $91.35 | $173K | 66,148 |
| 2024-09-13 | Basso Ronald Chief Legal & Compliance Off. | Sale | −4,741 | $77.92 | $369K | 39,434 |
| 2024-09-13 | CORASANTI JOSEPH J Director | Option exercise | +8,970 | $17.84 | $160K | 101,612 |
| 2024-09-13 | CORASANTI JOSEPH J Director | Sale | −8,970 | $77.39 | $694K | 92,642 |
| 2024-09-13 | CORASANTI JOSEPH J Director | Option exercise · Option (Right to buy) | −8,970 | 0 | ||
| 2024-09-10 | ANDERSON JAMES ROBERT CEO & President | Purchase | +500 | $70.55 | $35K | 148,214 |
| 2024-09-03 | ANDERSON JAMES ROBERT CEO & President | Purchase | +500 | $73.37 | $37K | 147,714 |
| 2024-08-29 | Martucci Richard J. Interim CFO & Treasurer | Grant or award | +12,867 | 40,149 | ||
| 2024-08-29 | Neal-Graves Lisa Director | Grant or award | +2,831 | 14,462 | ||
| 2024-08-29 | Koeppen Christopher Chief Innovation Officer | Grant or award | +9,007 | 68,047 |
Page 11 of 73 · 1,443 trades